<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="235">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on March 04, 2022</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04955210</url>
  </required_header>
  <id_info>
    <org_study_id>fdpicu-18</org_study_id>
    <nct_id>NCT04955210</nct_id>
  </id_info>
  <brief_title>A Multi-Center Data System and Collaborative Network in China for Severe Infection and Sepsis Children</brief_title>
  <official_title>Establishment of a Multi-Center Big Data System for Severe Infection and a Collaborative Network on Sepsis in Chinese Children</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Children's Hospital of Fudan University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Children's Hospital of Fudan University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      1. To research the current situation of severe infection in children in China, and to&#xD;
      investigate the incidence, prognosis and disease burden of severe infection in children in&#xD;
      different regions of China. 2. Establish the risk prediction model and diagnosi model of&#xD;
      severe infection in children, and verify the accuracy of the model in multi-center; 3. To&#xD;
      study the effectiveness and safety of different treatments in real diagnosis and treatment,&#xD;
      and to evaluate the efficacy of subgroups under different ages and high risk factors.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      1.Children between 0 and 18 years old. 2.Severe pneumonia and/or sepsis.Patients were&#xD;
      included who meet the guidline for diagnosis and treatment of community-acquired pneumonia in&#xD;
      Children (2019) issued by the National Health Commission of the people's Republic of China&#xD;
      and/or who meet the International Guide to the 2020 campaign to Save sepsis: management of&#xD;
      septic shock and sepsis-related organ dysfunction in children. 3.notifiable infectious&#xD;
      diseases.4.The researcher believes that he is not suitable to participate in other situations&#xD;
      in this study.5.Participants in other clinical trials in the same period.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">December 1, 2021</start_date>
  <completion_date type="Anticipated">June 30, 2025</completion_date>
  <primary_completion_date type="Anticipated">June 30, 2023</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>survival rate</measure>
    <time_frame>within 28 days after they discharged from PICU</time_frame>
    <description>The survival rate of children in 28 days after their discharged from PICU</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>length of stay in PICU</measure>
    <time_frame>within 28 days after they discharged from PICU</time_frame>
    <description>Time from PICU admission to discharge</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">5000</enrollment>
  <condition>Critical Illness</condition>
  <condition>Severe Sepsis</condition>
  <arm_group>
    <arm_group_label>Severe infection</arm_group_label>
    <description>Children with severe infection in PICU</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Not applicable（Cohort study）</intervention_name>
    <description>This is a prospective observational study and does not include interventions.</description>
    <arm_group_label>Severe infection</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        All children hospitalized in PICU of Children's Hospital of Fudan University from April&#xD;
        2021 to April 2025&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Children between 0 and 18 years old.&#xD;
&#xD;
          2. Severe pneumonia and/or sepsis.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. notifiable infectious diseases.&#xD;
&#xD;
          2. The researcher believes that he is not suitable to participate in other situations in&#xD;
             this study.&#xD;
&#xD;
          3. Participants in other clinical trials in the same period.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Guoping Lu</last_name>
    <role>Principal Investigator</role>
    <affiliation>The Children's Hospital of Fudan University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Guoping Lu</last_name>
    <phone>13788904150</phone>
    <email>13788904150@163.com</email>
  </overall_contact>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>March 26, 2021</study_first_submitted>
  <study_first_submitted_qc>July 4, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">July 8, 2021</study_first_posted>
  <last_update_submitted>October 20, 2021</last_update_submitted>
  <last_update_submitted_qc>October 20, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 22, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Sepsis</keyword>
  <keyword>Critical Illness</keyword>
  <keyword>severe infection</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infections</mesh_term>
    <mesh_term>Sepsis</mesh_term>
    <mesh_term>Toxemia</mesh_term>
    <mesh_term>Critical Illness</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

